Target intelligence / Profile preview

Coinhibitory Receptor (N/A)

Target
N/A
Molecular classification
Receptor, Transmembrane glycoprotein
01

Overview

Coinhibitory receptors are cell surface molecules expressed on activated T cells and other immune cells that transmit negative signals to dampen or terminate cellular activation. They are crucial for maintaining self-tolerance, preventing autoimmunity, and modulating responses to infections and cancer. Key members include PD-1, CTLA-4, LAG-3, TIGIT, and Tim-3. These receptors typically recruit intracellular phosphatases upon ligand binding, leading to reduced T cell activation. Therapeutic blockade of coinhibitory receptors has revolutionized cancer treatment but can also trigger immune-related adverse events.

Other names
Inhibitory checkpoint receptorImmune checkpoint
02

Mechanism of action

Engagement of coinhibitory receptors recruits intracellular phosphatases via phosphorylated ITIMs, leading to dephosphorylation of key signaling molecules downstream of the TCR pathway, reducing cellular activation, proliferation, cytokine production, and effector function.

03

Biological functions

Immune responseRegulation of T cell activationMaintenance of peripheral tolerancePrevention of autoimmunityRegulation of inflammation
04

Disease associations

AutoimmunityChronic InfectionCancer
05

Safety considerations

Immune-related adverse events (irAEs) due to loss of self-toleranceCytokine release syndromeExacerbation of autoimmune conditions
06

Interacting drugs

PD-1 inhibitors

5 more in the full profile.

07

Biomarkers

PD-L1 expressionTumor Mutational Burden (TMB)Microsatellite Instability (MSI)Coinhibitory receptor expression levels on immune cells

Beyond the preview

Go deeper on Coinhibitory Receptor (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coinhibitory Receptor (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call